← 返回

非小细胞肺癌中 MHC I 类分子显著缺失下 NK 细胞与 CD8 T 细胞的空间共定位及联合生存获益

英文原题:Spatial colocalization and combined survival benefit of natural killer and CD8 T cells despite profound MHC class I loss in non-small cell lung cancer.

查看英文原题

Spatial colocalization and combined survival benefit of natural killer and CD8 T cells despite profound MHC class I loss in non-small cell lung cancer.

PubMed 2024/09/18(内容时间) J Immunother Cancer Q1 · IF 11.7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

肿瘤浸润性 NK 细胞和 CD8 T 细胞共同影响 NSCLC 肿瘤进展的控制。NK 细胞和 CD8 T 细胞的共关联在 MHC-I 阳性肿瘤中最为明显,尤其是在 IFN 存在的情况下。在近邻分析中,IFN+NK 细胞与其他 IFN+淋巴细胞频繁共定位,提示 NSCLC 淋巴细胞活化受到协同调控。

研究思路结论见上方概要

主要组织相容性复合体I类(MHC-I)缺失在非小细胞肺癌(NSCLC)中很常见,使肿瘤细胞对T细胞裂解产生抵抗。NK细胞可杀伤MHC-I缺陷的肿瘤细胞,尽管既往研究表明它们存在于NSCLC边缘,但其功能受损。在此,我们评估了NK细胞和CD8 T细胞浸润及活化是否随MHC-I表达而变化。

我们使用单染免疫组织化学(IHC)和 Kaplan-Meier 分析来检验 NK 细胞和 CD8 T 细胞浸润对总生存期和无病生存期的影响。为阐明 MHC-I 差异型肺癌的免疫协变量,我们使用多重免疫荧光(mIF)成像,随后进行多变量统计建模。为识别 IFN 激活与未激活淋巴细胞在浸润和细胞间通讯方面的差异,我们开发了一个计算流程,从 mIF 图像中枚举单细胞邻域,随后进行多变量判别分析。

肿瘤细胞 MHC-I 表达的空间定量揭示了瘤内和瘤间异质性,这与局部淋巴细胞景观相关。IHC 分析显示,患者肿瘤中高 CD56+ 细胞数量与无病生存期(HR=0.58,p=0.064)和总生存期(OS)(HR=0.496,p=0.041)呈正相关。当 CD56+ 和 CD8+ 细胞计数均高时,OS 关联增强(HR=0.199,p<1 10 -3)。mIF 成像和多变量判别分析显示,携带 MHC-I 的肿瘤中 CD3+CD8+ T 细胞和 CD3-CD56+ NK 细胞均富集(p<0.05)。为了推断功能性细胞状态与局部细胞间通讯的关联,我们分析了空间单细胞邻域图谱,以描绘 IFN +/- NK 细胞和 T 细胞的细胞环境。我们发现,与 IFN- NK 细胞和 CD8 T 细胞相比,IFN+ NK 细胞和 CD8 T 细胞更常与其他 IFN+ 淋巴细胞相关联(p<1 10 -30)。此外,IFN+ 淋巴细胞最常被发现聚集在 MHC-I+ 肿瘤细胞附近。

展开英文摘要原文

Major histocompatibility complex class I (MHC-I) loss is frequent in non-small cell lung cancer (NSCLC) rendering tumor cells resistant to T cell lysis. NK cells kill MHC-I-deficient tumor cells, and although previous work indicated their presence at NSCLC margins, they were functionally impaired. Within, we evaluated whether NK cell and CD8 T cell infiltration and activation vary with MHC-I expression.

We used single-stain immunohistochemistry (IHC) and Kaplan-Meier analysis to test the effect of NK cell and CD8 T cell infiltration on overall and disease-free survival. To delineate immune covariates of MHC-I-disparate lung cancers, we used multiplexed immunofluorescence (mIF) imaging followed by multivariate statistical modeling. To identify differences in infiltration and intercellular communication between IFN -activated and non-activated lymphocytes, we developed a computational pipeline to enumerate single-cell neighborhoods from mIF images followed by multivariate discriminant analysis.

Spatial quantitation of tumor cell MHC-I expression revealed intratumoral and intertumoral heterogeneity, which was associated with the local lymphocyte landscape. IHC analysis revealed that high CD56 + cell numbers in patient tumors were positively associated with disease-free survival (HR=0.58, p=0.064) and overall survival (OS) (HR=0.496, p=0.041). The OS association strengthened with high counts of both CD56 + and CD8 + cells (HR=0.199, p<1 10 -3 ). mIF imaging and multivariate discriminant analysis revealed enrichment of both CD3 + CD8 + T cells and CD3 - CD56 + NK cells in MHC-I-bearing tumors (p<0.05). To infer associations of functional cell states and local cell-cell communication, we analyzed spatial single-cell neighborhood profiles to delineate the cellular environments of IFN +/- NK cells and T cells. We discovered that both IFN + NK and CD8 T cells were more frequently associated with other IFN + lymphocytes in comparison to IFN - NK cells and CD8 T cells (p<1 10 -30 ). Moreover, IFN + lymphocytes were most often found clustered near MHC-I + tumor cells.

Tumor-infiltrating NK cells and CD8 T cells jointly affected control of NSCLC tumor progression. Coassociation of NK and CD8 T cells was most evident in MHC-I-bearing tumors, especially in the presence of IFN . Frequent colocalization of IFN + NK cells with other IFN + lymphocytes in near-neighbor analysis suggests NSCLC lymphocyte activation is coordinately regulated.

论文信息

作者
Wessel RE、Ageeb N、Obeid JM、Mauldin IS、Goundry KA、Hanson GF、Hossain M、Lehman C
第一作者单位
Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA.United States
通讯作者单位
Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA sdolatshahi@virginia.edu.United States
期刊
Journal for immunotherapy of cancer2024 Sep 18
原文标识
PubMed 39299754 · DOI 10.1136/jitc-2024-009126